Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) (FGCRT)
Foscarnet-Ganciclovir CMV Retinitis Trial
Sponsor: Baylor College of Medicine
A PHASE3 clinical study on Cytomegalovirus Retinitis and HIV Infections, this trial is completed. The trial is conducted by Baylor College of Medicine and has accumulated 8 data snapshots since 1990. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE3
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE3
▶ Show 3 earlier versions
-
Jun 2019 — Jan 2021 [monthly]
Completed PHASE3
-
Jun 2018 — Jun 2019 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Mar 1990
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baylor College of Medicine
- Icahn School of Medicine at Mount Sinai
- Johns Hopkins Bloomberg School of Public Health
- Johns Hopkins University
- Louisiana State University Health Sciences Center in New Orleans
- Memorial Sloan Kettering Cancer Center
- NYU Langone Health
- National Eye Institute (NEI)
- New York Presbyterian Hospital
- Northwestern University
- University of California, Los Angeles
- University of California, San Diego
- University of California, San Francisco
- University of Massachusetts, Worcester
- University of Miami
- University of Wisconsin, Madison
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.